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Dietary calcium and serum 1,2540H)2-vitamin D concentrations as
determinants of calcium balance in healthy men. We previously reported
that experimental elevations of serum I ,25-(OH)2-vitamin D [1 ,25-(OH)2-
Di concentrations produced by the chronic oral administration of
calcitriol, 0.75 ig every 6 hr, to healthy human males eating diets
providing only 4 mmoles Ca/day stimulate net bone resorption as
evidenced by more negative Ca balances and higher rates of urinary
hydroxyproline excretion. To determine whether increased dietary Ca
intake modifies this response we have compared serum I ,25-(OH)2-D
and iPTH concentrations, Ca and P04 balances, and urinary
hydroxyproline excretion in three healthy human males adapted to diets
providing 22.3 1.3 mmoles Ca/day and three healthy human males
adapted to diets providing 9.3 0.7 mmoles Ca/day before and during
the continuous oral administration of calcitriol 0.5 sg every 6 hr. For all
six subjects, serum I ,25-(OH)2-D levels averaged 89 25 M during
control and 143 26 M during calcitriol. Net intestinal Ca absorption
and urinary Ca excretion rose during calcitriol but Ca balances did not
change, averaging +2.2 2.2 mmoles/day during control and +4.3
2.2 mmoles/day during calcitriol for the subjects fed 22 mmoles Ca/day
and —1.6 l.SmmolesCa/dayduringcontroland —1.7 2,Ommoles
Ca/day during calcitriol for the subjects fed 9 mmoles Ca/day. Urinary
hydroxyproline excretion also did not change. Thus, when serum
1 ,25-(OH)2-D levels are elevated, the availability of dietary Ca appears
to prevent more negative Ca balances and increased urinary
hydroxyproline excretion suggesting that net bone resorption is not
stimulated.
Le calcium alimentaire et les concentrations sériques de I ,25-(OH)2.
vitamine D determinants de La balance calcique chez des hommes sains.
Nous avons prealablement rapporté que des élévations expérimentales
des concentrations sériques de I ,25-(OH)2-D par administration
chronique orale de calcitriol, 0,75 toutes les 6 heures a des hommes
sains ingerant des regimes n'apportant que 4 mmoles Ca/jour stimulent
la resorption osseuse nette, ce qui est mis en evidence par des balances
Ca plus negatives et par des debits d'excrétion urinaire d'hydroxy-
proline plus élevés. Afin de determiner si une augmentation de l'apport
en Ca alimentaire modifie cette réponse, nous avons compare les
concentrations seriques de l,25-(0H)-D et d'iPTH, les balances Ca et
PU4 et l'excrCtion urinaire d'hydroxyproline chez trois hommes sains
adaptés a des regimes apportant 22,3 1,3 mmoles Ca/jour et chez
trois hommes sains adaptds a des regimes apportant 9,3 0,7 mmoles
Ca/jour avant et pendant l'administration orale continue de calcitriol,
0,5 sg toutes les 6 heures. Pour les six sujets, les niveaux seriques de
1 ,25-(OH)2-D étaient en moyenne de 89 25 pM pendant le contrôle et
de 143 26 M pendant le calcitriol. L'absorption intestinale nette de
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Ca et I'excrétion urinaire de Ca se sont élevées pendant Ic calcitriol,
mais les balances Ca n'ont pas change, étant en moyenne de + 2,2
2,2 mmoles/jour pendant le contrôle et de 4,3 2,2 mmoles/jour
pendant le calcitriol chez les sujets ingérant 22 mmoles Ca/jour et de
— 1,6 1,5 mmoles Ca/jour pendant le contrôle et de 1,7 2,0 mmoles
Ca/jour pendant le calcitriol chez les sujets ingerant 9 mmoles Ca/jour.
L'hydroxyproline urinaire aussi ne s'est pas modifiée. Ainsi, lorsque les
niveaux seriques de 1,25-(OH)2-D sont eleves, la disponibilite du
calcium alimentaire parait prévenir des balances Ca plus negatives et
une excretion urinaire d'hydroxyproline elevee, suggérant que Ia
resorption osseuse nette n'est pas stimulee.
We have previously reported that when serum l,25-(OH)2-
vitamin D [1,25-(OH)2-D] levels were experimentally elevated
in healthy men eating diets providing only 4 mmoles Ca/day,
urinary calcium excretion rates exceeded the level of dietary
calcium intake [1]; calcium balances became more negative and
urinary hydroxyproline excretion increased [21. Those observa-
tions provide indirect evidence that 1 ,25-(OH)2-D is capable of
stimulating bone resorption in humans as it does in rats [3] and
in cultured rat bone [4].
Patients that form calcium oxalate/apatite kidney stones may
exhibit elevated serum I ,25-(OH)2-D levels [5—7]. Slightly re-
duced bone mass has also been noted among these patients [6,
8—11], but symptomatic bone disease does not occur. Although
dietary calcium restriction is often recommended for such
patients, they seldom eat diets providing as little as 4 mmoles
Ca/day. Thus, it seemed possible that the availability of dietary
calcium might serve to protect the skeleton when serum 1,25-
(OH)2-D concentrations are elevated. To explore this possibil-
ity, we have now evaluated calcium balances in healthy men
eating diets providing either 22 or 9 mmoles Ca/day before and
during experimental elevations of serum l,25-(OH)2-D concen-
trations achieved by the ongoing administration of calcitriol.
Methods
We studied six healthy human males ranging in age from 24 to
37 years in the Medical College of Wisconsin Clinical Research
Center with their consent and the approval of the Medical
College of Wisconsin Human Research Review Committee.
Each subject ate two comparable constant whole food diets that
were alternated daily. Subjects A, B, and C ate diets providing
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normal amounts of calcium, averaging for this group 22.3 1.3
SD mmoles/day, while subjects D, E, and F ate diets that
provided a moderately restricted calcium intake, averaging for
this group 9.3 0.7 mmoles/day. The diets were otherwise
similar in composition, providing for all six subjects an average
of P04 56 6 mmoles/day, Mg 1.61 1.4 mmoles/day, Na 176
13 mmoles/day, and K 76 4 mmoles/day, as well as an
estimated 40 to 48 kcal/kg body weight/day.
Each subject was adapted to his diet for 4 days and then
observed during two 6-day control balance periods. Two ad-
ditional control days were utilized to permit passage of the
carmine marker given at the end of the second control period.
Each subject was then begun on continuous oral calcitriol, 0.5
g every 6 hr, and observed during 4 days of adaptation
followed by three 6-day balance periods. Although carmine was
used to mark the 6-day fecal peiods, feces were actually pooled
every 1 to 4 days in individual subjects to permit more frequent
estimates of fecal mineral excretion. Twenty-four-hour urine
specimens were collected and, in addition, 6-day urine pools
were prepared for some measurements. Morning fasting blood
samples were obtained on 4 control days and on 7 calcitriol days
6 hr after the last dose of calcitriol. Additional blood samples
were collected during the day at times corresponding to 2 and 4
hr after the previous dose of calcitriol during both the control
and calcitriol periods. Fasting morning urine specimens were
collected at the end of the second control and third calcitriol
periods.
The analytical methods used for the estimation of mineral
balances, serum parathyroid hormone (iPTH), urinary oxalate,
and urinary hydroxyproline, have been previously reported [21.
Serum vitamin D metabolites were measured by protein binding
assays also as previously described [2]. The interassay co-
efficient of variation for the measurement of serum I ,25-(OH)2-
D averaged 18% (N = 35) during the time the studies were
carried out. The intra-assay coefficient of variation was deter-
mined on two occasions and averaged 11 (N = 7) and 9% (N =
4). All serum samples for the measurement of 1,25-(OH)2-D
from a given study were measured in the same assay.
Results are presented either as individual data for each
subject or group means SD. The individual average results for
the second and third calcitriol periods were compared to those
in the two control periods by paired t test. We have also
compared the results of the present studies to previously
reported unpaired observations of four healthy men studied
during periods beginning 10 days after they began eating whole
food diets providing only 4.0 0.2 mmoles Ca/day and
observations of four healthy men studied during periods begin-
ning 10 days after they began eating similar low calcium diets
and began taking calcitriol, 0.75 g every 6 hr [21.
Results
The measurements of serum composition, daily and fasting
urinary composition and mineral balances are summarized in
Tables I and 2. Figure 1 presents the components of calcium
balance for each of the three subjects who ate the diets
providing normal amounts of calcium, while Figure 2 presents
the components of calcium balances for the three subjects who
ate the diets providing moderately restricted amounts of cal-
cium.
As shown in the left-hand column of Table I, serum composi-
tion was normal. Individual average serum l,25-(OH)2-D levels
among the six subjects ranged from 54 to 126 pmoles/liter and
were stable in each. The average of the individual coefficients of
Control
Table 1. Fasting serum and urine composition: creatinine clearance and daily urinary hydroxyproline excretion in subjects eating diets
providing normal or moderately reduced quantities of calcium
&Calcitriol
Number of subjects
1 ,25-(OH)2-D,
pmo/es/liter
25-0H-D, flM
nmoiesiliter
Ca, mmolesiliter
P04, mmoles/liter
iPTH, j.dEq/ml
Mg, mmoles/liter
Creatinine,
/2moles/izter
Creatinine clearance,
mi/minI] .73 m2
Fasting urine Ca/creatinine,
mmolesImmoles
Fasting TmPO41GFR,
mmoiesIliter
Fasting urine oxalate/creatinine,
/.Lmoies/mmoies
Urinary hydroxyproline,
mmoles/day
+54
6
89
40
2.32 0.08
1.32 0.14
3.4 2.0
0.88 0.06
101 7
110
0.180 0.117
1.34 0.18
20 4
0.292 0.079
0
+ 0.04
+ 0.06
—1.8
—0.04
0.03
0.10
1.6
0.04
6
143
40
2.36 0.09
1.38 0.18
1.6 0.7
0.84 0.07
108 9
103
0.428 0.086
1.25 0.20
19 2
0.268 0.081
<0.005
NS
<0.05
NS
<0.05
NS
<0.025
<0.001
<0.005
NS
NS
NS
+7
—7
+0.248 0.097
—0.09 0.12
—1
—0.024 .037
a These values reflect the probability that observations during calcitriol do not differ from control observations.
b Values throughout the table are group means so.
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Table 2. Body weight, serum I ,25-(OH)2-D concentrations, calcium, phosphorus, and magnesium balance, and fecal weights during control and
during calcitriol administration in subjects who ate diets providing normal or moderately restricted amounts of calcium
Normal calcium diet Restricted calcium diet
Control Calcitriola jd Control Calcitriol Jb
Number of subjects 3 3
Body weight, kg 76.9 6.9 69.5 10.8
Serum 1 ,25-(0H)2-D,
pmo!es
Ca, mmoles/day
Fecal Ca, mmoles/day
Net intestinal Ca
absorption, mmoleslday
Urine Ca, mmoleslday
Ca balance, mmoleslday
80 26
22.3 1.3
15.5 1.2
6.8 2.0
4.6 2.8
+2.2 2.2
138 37
22.3 1.3
6.2 2.4
16.1 3.5
11.8 1.4
+4.3 2.2
58 33
0
—9.3 1.5
+9.3 1.5
+7.2 1.7
+2.1 2.7
NS
NS
<0.01
<0.01
<0.025
NS
98
9.3
7.7
1.6
3.2
—1.6
25
0.7
1.4
0.9
1.7
1.5
149 14
9.3 0.7
3.4 1.2
5.9 0.9
7.6 2.2
—1.7 2.0
51 12
0
—4.3 0.2
+4.3 0.2
+4.4 0.7
—0.1 0.6
<0.025
NS
<0.01
<0.01
<0.01
NS
Diet P04, mmoleslday
Fecal P04, mmoleslday
Net intestinal P04
absorption, mmoleslday
Urine P04, mmoleslday
P04 balance, mmoles/day
51.1 3.0
17.9 3.7
33.2 4.3
25.8 2.0
+7.4 2.4
51.1 3.0
10.9 3.7
40.2 3.9
28.0 1.4
+12.2 3.8
0
—7.0 0.6
+7.0 0.6
+2.2 1.8
+4.8 1.8
NS
<0.01
<0.01
NS
<0.05
60.7
16.5
44.2
32.9
+11.3
3.8
1.7
2.2
6.7
4.6
60.7 3.8
12.3 4.5
48.5 2.8
38.7 4.4
+9.8 4.8
0
—4.2 3.0
+4.3 3.0
+5.8 2.8
—1.5 4.6
NS
NS
NS
NS
NS
Diet Mg, mmoleslday
FecalMg, mmoles/day
Net intestinal Mg
absorption, mmoles/day
Urine Mg, mmoles/day
Mg balance, mmoleslday
15.2 0.8
8.3 1.4
6.9 1.3
5.4 0.5
+1.5 0.9
15.2 0.8
7.2 1.9
8.0 1.8
6.0 0.8
+2.0 1.1
0
—1.1 0.5
+1.1 0.5
+0.6 0.4
+0.5 0.2
NS
NS
NS
NS
NS
17.0
8.9
8.1
4.8
+3.3
1.2
1.1
0.9
1.0
1.6
17.0 1.2
8.8 3.1
8.2 2.0
5.3 0.7
+2.9 2.4
0
—0.1 2.7
+0.1 2.7
+0.5 0.3
—0.4 2.6
NS
NS
NS
NS
NS
Fecal weight, glday 96 38 100 55 +4 25 NS 152 121 147 123 —5 25 NS
a Calcitriol refers to observations during the second and third 6-day periods of calcitriol administration (that is, days 11 through 22 of calcitriol
administration).
Probability that observations during calcitriol do not differ from control observations based on t test for paired groups.
variation was 19%. Creatinine clearances, fasting urine compo-
sition, and daily urinary hydroxyproline excretion rates were
also normal.
Fecal calcium excretion rates, and thus rates of net intestinal
calcium absorption, as well as urinary calcium excretion rates
were stable in the three subjects eating the diets providing
normal amounts of calcium (Fig. I) and in the subjects eating
the diets providing moderately restricted amounts of calcium
(Fig. 2). Control calcium balances were also stable and aver-
aged + 2.2 2.2 mmoles/day for the three subjects eating the
normal calcium diet and — 1.6 1.5 mmoles/day for the three
subjects eating the restricted calcium diets (Table 2). Neither of
these means are different from zero. Control phosphorus and
magnesium balances were also stable and positive (Table 2).
Effects of calcitriol
As shown in Table 1, the continuous administration of
calcitriol, 0.5 rg every 6 hr, raised mean serum 1 ,25-(OH)2-D
levels for the group to 143 26 pmoles/liter. As observed in
previous studies l, 2], stable elevated l,25-(OH)2-D levels
were produced in each subject and ranged from 101 to 175
pmoles/liter in individual subjects (data not shown). The aver-
age of the individual coefficients of variation for the measure-
ments of serum 1 ,25-(OFI)2-D during calcitriol administration
for the group was 28%.
When serum 1,25-(OH)2-D levels were experimentally in-
creased, fecal calcium excretion decreased as expected so that
net intestinal calcium absorption and urinary calcium excretion
increased among the three subjects who ate the normal calcium
diets (Fig. 1) and among the three subjects who ate the
moderately restricted calcium diets (Fig. 2). These increments
stabilized during the second and third 6-day balance periods
while calcitriol was administered—that is, from days 11 to 22 of
calcitriol administration (Figs. I and 2). During these last two
6-day periods of calcitriol administration, the increments in
urinary calcium excretion nearly matched the increments in net
intestinal calcium absorption. Thus, calcium balances became
slightly more positive among the three subjects who ate the
normal calcium diets and very slightly more negative among the
three subjects who ate the moderately restricted calcium diets
(Table 2), but neither of these changes were significant. Phos-
phorus balances were more positive than control among the
subjects who ate the normal calcium diets. Magnesium balances
were not altered by calcitriol administration.
As intestinal calcium absorption increased, fasting serum
calcium concentrations for the group increased significantly
(Table 1). This increment was somewhat greater, averaging
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+0.10 0.07 mmoles/liter for the group (P < 0.025), when
serum calcium levels during the day were also evaluated, as
previously observed UI. Serum iPTH thus fell (Table I). Serum
creatinine concentrations rose slightly but significantly during
calcitriol administration, and creatinine clearances fell (Table
1). Neither serum P04 concentrations nor fasting TmPO4/GFR
changed during calcitriol. Fasting urinary calcium/creatinine
increased as expected 11, 21. Neither fasting urinary oxalate nor
daily urinary hydroxyproline excretion changed (Table I).
Discussion
Control conditions
During the control phases of the present studies, serum
1,25-(OH)2-D levels were within the normal range [12—211 and
stable as we have reported previously [1, 2, 221. Rates of net
intestinal calcium absorption and urinary calcium excretion
were steady in each subject (Figs. 1 and 2). Thus, calcium
balances, which averaged + 2.2 2.2 for the subjects eating 22
mmoles Ca/day and —1.6 1.5 mmoles/day for the subjects
eating 9 mmoles Ca/day, were stable (Figs. I and 2). These
calcium balances are quantitatively similar to those reported by
MaIm [23]. In those long-term studies of healthy men, Ca
balances averaged 2.0 1.8 mmoles/day among 39 subjects
who ate diets providing 23.4 1.0 mmoles Ca/day and —0.8
1.0 mmoles/day among 26 subjects who ate diets providing 11.5
1.4 mmol Ca/day.
Effects of calcitriol
The administration of calcitriol, 2 pg/day or 4.8 nmoles/day,
produced stable elevated serum I ,25-(OH)2-D concentrations
[1, 2]. Although rates of net intestinal calcium absorption and
urinary calcium excretion increased, as expected, when
calcitriol administration was begun, there was a delay of about
10 days until stable higher rates were achieved (Figs. I and 2),
as previously observed when calcitriol was administered to
subjects eating diets providing only 4.0 mmoles Ca/day [2]. The
increments observed in net intestinal Ca absorption were simi-
lar to those reported for subjects eating comparable amounts of
calcium while being given 2.7 xg or 6.4 nmoles calcitriol/day
[24].
Interaction of dietary calcium intake and serum l,25-(OH)2-D
levels on net intestinal calcium absorption, urinary calcium
excretion, and calcium balance
Figure 3 summarizes the relationships of net intestinal cal-
cium absorption, urinary calcium excretion and calcium bal-
ance to prevailing serum I ,25-(OH),-D concentrations in the
men eating diets providing 22 or 9 mmoles/Ca/day during
control and during calcitriol administration together with our
previously reported observations in men eating diets providing
only 4 mmoles Ca/day, alone or during the administration of
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Net intestinal Ca absorption Urine Ca Ca balance
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DietCa22, 16
mmoles/day//
/
4/ 6
Diet Ca 4,
Immoles/day 4/ • y
2
i 0
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Serum 1,25—(OH)2D, pmo/es//iter
Fig. 3. Relationship of net intestinal Ca
absorption, urinary Ca excretion, and calcium
balance to prevailing serum 1,25-(OH)2-D
concentrations during control periods (open
symbols) and during experimental elevations of
serum 1,25-(OH)2-D levels (solid symbols) in
subjects eating diets providing an average of 22
mmoles Ca/day (squares), 9.3 mmoles Ca/day
(triangles), and 4.0 mmoles Ca/day (circles). The
subjects who ate the diets providing 22 and 9.3
mmoles Ca/day were given 0.5 g calcitriol every
6 hr, while the subjects who ate the 4 mmoles
Ca/day diet were given 0.75 ig calcitriol every
6 hr.
Table 3. Relationships of net intestinal Ca absorption, urinary Ca, and 0.60 -
Ca balance to serum 1 ,25-(OH)2-D levels in subjects eating diets
providing 22, 9, or 4 mmoles Ca/day
Diet Ca Intercept Slope r P
0.50 -
a)
0.40 -
0.92 0.01 >
0.95 <0.01 2 .5 0.30 -
0.70 0.05 2>.t
a)
0.87 <0.05
.
0.20 -
0.70 0.05
0.83 <0.05
Calcium balance, mmo/es/day
calcitriol, 3 pg/day.' Table 3 summarizes the regression rela-
tionships shown in Figure 3. As shown in the left-hand panel of
Figure 3, the magnitude of net intestinal calcium absorption at
any given serum 1 ,25-(OH)2-D concentration depended as ex-
pected, on the availability of dietary calcium (Table 3). The
absolute increments in net intestinal calcium absorption at any
prevailing serum I ,25-(OH)2-D level were directly related to
dietary calcium intake.
As shown in the middle panel of Figure 3, urinary calcium
excretion rates were also directly related to prevailing serum
l,25-(OH)2-D concentrations. At any prevailing serum 1,25-
(OH)2-D level, urinary calcium excretion was also directly
related to dietary calcium intake (Table 3).
As shown in the right-hand panel of Figure 3, when dietary
calcium intake was normal, calcium balances tended to become
'We chose a dose of 2 tg calcitriol daily for the present studies because
of the potential risks of more marked hypercalciuria when greater
quantities of dietary calcium were available for absorption.
Fig. 4. Relationship of daily urinary hydroxyproline excretion to daily
Ca balance among subjects studied during control periods (open
symbols) and during experimental elevation of serum 1,25-(OH)2-D
concentrations (solid symbols) while eating diets providing an average
of 22 mmoles Ca/day (squares), 9.3 mmoles Ca/day (triangles), or 4.0
mmoles/day (circles). The subjects who ate the diets providing 22 and
9.3 mmoles Ca/day were given 0.5 .tg calcitriol every 6 hr, while the
subjects who ate the 4 mmoles Ca/day diet were given 0.75 sg calcitriol
every 6 hr.
more positive as serum 1 ,25-(OH)2-D levels were experimen-
tally elevated. When dietary calcium intake was moderately
restricted, control calcium balances were slightly negative and
did not change as serum 1 ,25-(OH)2-D levels were elevated (see
also Fig. 2). By contrast, when dietary calcium intake was very
low, calcium balances became significantly more negative as
serum l,25-(OH)2-D levels were increased (Table 3).
That these more negative Ca balances reflect bone resorption
is supported by the data in Figure 4, which shows that urinary
hydroxyproline excretion, another reflection of net bone
resorption, rose as calcium balances became more negative,
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Fig. 5. Serum immunoreactive PTH in relation to serum 1,25-(OH)2-D
concentrations for the subjects studied during control periods (open
symbols) and during experimental elevation of serum 1,25-(OH)2-D
concentrations (solid symbols) while eating diets providing an average
of 22 mmoles Ca/day (squares), 9.3 mmoles Ca/day (triangles), or 4.0
mmoles Ca/day (circles). The subjects who ate the diets providing 22
and 9.3 mmoles Ca/day were given 0.5 g calcitriol every 6 hr while the
subjects who ate the 4 mmoles Ca/day diets were given 0.75 .tg calcitriol
every 6 hr. The solid lines indicate the trends for serum iPTH concen-
trations to fall as serum l,25-(OH)2-D concentrations were elevated.
None were statistically significant (diet Ca 22 mmoles/day: r = —0.33;
diet Ca 9 mmoles/day: r =
—0.66; diet Ca 4 mmoles/day: r = —0.68).
especially when serum 1 ,25-(OH)2-D levels were increased
among subjects who ate a low calcium diet [2],
One possible explanation for the more negative calcium
balances among the subjects given 1 ,25-(OH)2-D3 while eating
the very low calcum diet might be that these subjects were
given a 50% greater dose of calcitriol which resulted in higher
average serum I ,25-(OH)2-D levels than among the subjects
who ate the moderately restricted or normal calcium diets,
Speculatively, if bone is less sensitive to prevailing serum
1,25-(OH)2-D concentrations than the intestine, the more nega-
tive calcium balances may simply be the result of bone resorp-
tion caused by higher serum 1,25-(OH)2-D levels, Alternatively,
the possible role of PTH to stimulate bone resorption requires
consideration. Figure 5 shows mean serum iPTH concentra-
tions for each of the subjects fed the three levels of dietary
calcium intake as a function of their individual mean serum
1 ,25-(OH)2-D concentrations during control and during
calcitriol administration. Serum iPTH levels, as expected, were
highest among the subjects who ate the very low calcium diet
and lowest among the subjects who ate the normal calcium diet.
Serum iPTH levels tended to be lower when serum 1 ,25-(OH)2-
D levels were elevated by the administration of calcitriol.
However, despite the administration of a 50% larger dose of
calcitriol to the subjects who ate the 4-mmoles Ca/day diet, and
the resulting higher serum 1 ,25-(OH)2-D concentrations, serum
iPTH levels remained higher compared to subjects fed the
greater calcium intakes. Thus, a failure to maximally inhibit
PTH when dietary calcium intake was very low may have
contributed to the stimulation of bone resorption and more
negative calcium balances. Clearly, PTH alone cannot entirely
explain the more negative calcium balances and increased rates
of urinary hydroxyproline excretion seen among patients given
calcitriol while eating the very low calcium diet. As shown in
Figure 4, the calcium balances were most negative and urinary
hydroxyproline excretion rates highest in these subjects. How-
ever, as shown in Figure 5, these subjects had lower iPTH
levels than the subjects who ate the very low calcium diet alone.
Thus, both PTH and I ,25-(OH)2-D may contribute to the
stimulation of bone resorption when dietary calcium is severely
limited.
The relationship of calcium balances to the level of dietary
calcium intake and to serum l,25-(OH)2-D concentrations was
also evaluated by multiple linear regression: Calcium bal-
ance, mmoles/day = —3.56 + 0.377 diet calcium, mmoles/day
—0.0146 serum l,25-(OH)2-D, pmoles/liter; r = 0.84. This
relationship indicates that at an average normal serum 1,25-
(OH)2-D level of 85 pmoles/liter, a dietary calcium intake of 15.4
mmoles/day would be necessary to produce a calcium balance
of + 1 mmoles/day, slightly positive to account for unmeasured
losses. At a low normal serum l,25-(OH)2-D level of 40
pmoles/liter, a dietary Ca intake of 11 mmoles/day would be
necessary to sustain a mean Ca balance greater than zero. By
contrast, at a high normal serum l,25-(OH)2-D level of 140
pmoles/liter, dietary Ca intake would need to average 15.4
mmoles/day to sustain a Ca balance greater than zero. When
serum l,25-(OH)2-D levels exceed 140 pmoles/liter, dietary
calcium intake must increase even more to sustain positive
calcium balances. A dietary Ca intake of 14 mmoles/day or
more would permit a positive Ca balance at a serum 1 ,25-(OH)2-
D level of 125 pmoles!liter, an approximate average value for
patients with nephrolithiasis and hypercalciuria [5—7]. Even at a
serum 1 ,25-(OH)2-D concentration of 250 pmoles/liter, a dietary
Ca intake of only 19 mmoles/day would be sufficient to achieve
a Ca balance of zero. Since approximately two-thirds of human
males in the United States aged 18 to 44 yr eat diets providing
more than 14 mmoles Calday [251, it seems reasonable to
speculate that such higher intakes are protective against the
development of bone disease among patients with
nephrolithiasis and elevated serum 1 ,25-(OH)2-D levels.
Although calcium balances are directly related to dietary
calcium intake and inversely related to serum l,25-(OH)2-D
levels, urinary calcium excretion is directly related to both:
Urine calcium, mmoles/day = —3.9 + 0.273 diet calcium,
mmoles/day + 0.0558 serum l,25-(OH)2-D, pmoles/liter; r =
0.83. Thus, the effect of increasing dietary calcium to protect
against negative calcium balances when serum 1 ,25-(OH)2-D
levels are elevated occurs at the expense of more marked
hypercalciuria. Urinary calcium excretion will, on the average,
exceed 7.5 mmoles/day, the generally accepted upper limit of
the normal range, when dietary calcium intake is 20 mmoles/day
and serum 1 ,25-(OH)2-D levels exceed 110 pmoles/liter, a value
still within the normal range. Speculatively, therefore, individu-
als with serum 1 ,25-(OH)2-D levels that are chronically only
about 30% above the normal mean would be vulnerable to
hypercalciuria while eating diets providing 20 mmoles Ca/day or
more. Given the variation in the analytical determination of
serum 1 ,25-(OH)2-D concentrations, such elevations would be
difficult to detect without multiple measurements in the same
subject.
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Finally, the relationships between morning fasting urinary
calcium/creatinine concentration ratio and dietary calcium or
serum I ,25-(OH)7-D levels require consideration. As shown in
the left-hand panel of Figure 6, fasting calcium/creatinine was
unrelated to dietary calcium intake either when serum 1,25-
(OH)2-D levels were normal or experimentally elevated. By
contrast, the present studies confirm that fasting urinary
calciuni/creatinine is closely correlated to prevailing serum
I ,25-(OH)2-D concentrations at all levels of dietary calcium
intake [I]. This relationship was evident even for the control
studies (that is, in the absence of calcitriol administration)
among the subjects eating diets providing varying quantities of
calcium: fasting urine calcium/creatinine mmoles/mmoles =
—0.205 + 0.00418 serum l,25-(OH)2-D, pmoles/liter; r = 0.94.
Fasting urinary Ca/creatinine is generally thought to be a
reflection of net bone resorption [261. Thus, these data suggest
that I ,25-(OH)2-D is an important determinant of bone re-
sorption in healthy men regardless of dietary Ca intake. More-
over, since in the present studies fasting urinary Ca/creatinine
ratios were not significantly correlated to Ca balances (r =
—0.26), it would appear that nocturnal bone resorption can be
compensated for during the day when Ca is available in the diet.
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